Skip to main content
logo
UltraTech Cement Limited (NSE:ULTRACEMCO)
India flag India · Delayed Price · Currency is INR
12,249
-19 (-0.15%)
Jul 31, 2025, 3:30 PM IST

Achilles Therapeutics Revenue

UltraTech Cement had revenue of 212.75B INR in the quarter ending June 30, 2025, with 17.74% growth. This brings the company's revenue in the last twelve months to 784.12B, up 10.07% year-over-year. In the fiscal year ending March 31, 2025, UltraTech Cement had annual revenue of 759.55B with 7.12% growth.

Revenue (ttm)
784.12B
Revenue Growth
+10.07%
P/S Ratio
4.60
Revenue / Employee
33.13M
Employees
23,670
Market Cap
3,608.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025759.55B50.47B7.12%
Mar 31, 2024709.08B76.68B12.13%
Mar 31, 2023632.40B106.41B20.23%
Mar 31, 2022525.99B78.73B17.60%
Mar 31, 2021447.26B22.96B5.41%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Asian Paints338.65B
Grasim Industries1,484.78B
Vedanta1,513.36B
Pidilite Industries131.40B
Solar Industries India75.40B
Shree Cement192.83B
Jindal Steel497.65B
Coromandel International263.99B
Revenue Rankings

UltraTech Cement News

More News